Role of ERK1/2 signaling during EGF-induced inhibition of palatal fusion

Developmental Biology

Volumn 260, Issue 2, 2003, Pages 512-521

  Yamamoto, Tadashi ^a   Cui, Xiao Mei ^a   Shuler, Charles F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cell proliferation; EGF; ERK1 2 signaling; Medial edge epithelium; Mouse; Organ culture; Palatogenesis

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; BROXURIDINE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CLEFT PALATE; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME INHIBITION; EPITHELIUM CELL; FEMALE; MAMMAL; MOUSE; NONHUMAN; ORGAN CULTURE; PALATE; PHENOTYPE; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0043063075     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0012-1606(03)00275-6     Document Type: Article

References (50)

1. Abbott B.D., Adamson E.D., Pratt R.M. Retinoic acid alters EGF receptor expression during palatogenesis. Development. 102:1988;853-867.
2. Abbott B.D., Birnbaum L.S. TCDD alters medial epithelial cell differentiation during palatogenesis. Toxicol. Appl. Pharmacol. 99:1989;276-286.
3. Brunet A., Roux D., Lenormand P., Dowd S., Keyse S., Pouyssegur J. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18:1999;664-674.
4. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature. 410:2001;37-40.
5. Cui X.M., Shuler C.F. The TGF-beta type III receptor is localized to the medial edge epithelium during palatal fusion. Int. J. Dev. Biol. 44:2000;397-402.
6. Cui X.M., Chai Y., Chen J., Yamamoto T., Ito Y., Bringas P., Shuler C.F. TGF-b3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion. Dev. Dyn. 2003;. in press.
7. Eggenschwiler J., Ludwig T., Fisher P., Leighton P.A., Tilghman S.M., Efstratiadis A. Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes. Genes Dev. 11:1997;3128-3142.
8. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:1998;18623-18632.
9. Ferguson M.W. Palate development. Development. 103:1988;41-60.
10. Ferguson M.W. Craniofacial malformations towards a molecular understanding . Nat. Genet. 6:1994;329-330.
11. Fisher D.A., Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr. Rev. 11:1990;418-442.
12. Formstecher E., Ramos J.W., Fauquet M., Calderwood D.A., Hsieh J.C., Canton B., Nguyen X.T., Barnier J.V., Camonis J., Ginsberg M.H., Chneiweiss H. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Del. Cell. 1:2001;239-250.
13. Gehris A.L., Pisano M.M., Nugent P., Greene R.M. Regulation of TGF beta 3 gene expression in embryonic palatal tissue. In Vitro Cell Dev. Biol. 30A:1994;671-679.
14. Graves L.M., Guy H.I., Kozlowski P., Huang M., Lazarowski E., Pope R.M., Collins M.A., Dahlstrand E.N., Earp H.S. 3rd, Evans D.R. Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature. 403:2000;328-332.
15. Greene R.M. Signal transduction during craniofacial development. Crit. Rev. Toxicol. 20:1989;137-152.
16. Greene R.M., Pratt R.M. Developmental aspects of secondary palate formation. J. Embryol. Exp. Morphol. 36:1976;225-245.
17. Hackel P.O., Zwick E., Prenzel N., Ullrich A. Epidermal growth factor receptors critical mediators of multiple receptor pathways . Curr. Opin. Cell Biol. 11:1999;184-189.
18. Hassell J.R. The development of rat palatal shelves in vitro. An ultrastructural analysis of the inhibition of epithelial cell death and palate fusion by the epidermal growth factor. Dev. Biol. 45:1975;90-102.
19. Hudson C.D., Shapiro B.L. A radioautographic study of deoxyribonucleic acid synthesis in embryonic rat palatal shelf epithelium with reference to the concept of programmed cell death. Arch. Oral Biol. 18:1973;77-84.
20. Kaartinen V., Cui X.M., Heisterkamp N., Groffen J., Shuler C.F. Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Dev. Dyn. 209:1997;255-260.
21. Kaartinen V., Voncken J.W., Shuler C., Warburton D., Bu D., Heisterkamp N., Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11:1995;415-421.
22. Khokhlatchev A.V., Canagarajah B., Wilsbacher J., Robinson M., Atkinson M., Goldsmith E., Cobb M.H. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell. 93:1998;605-615.
23. Kling D.E., Lorenzo H.K., Trbovich A.M., Kinane T.B., Donahoe P.K., Schnitzer J.J. MEK-1/2 inhibition reduces branching morphogenesis and causes mesenchymal cell apoptosis in fetal rat lungs. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L370-L378.
24. Kolch W. Meaningful relationships the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions . Biochem. J. 351:2000;289-305.
25. Kretzschmar M., Doody J., Timokhina I., Massague J. A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes Dev. 13:1999;804-816.
26. Like B., Massague J. The antiproliferative effect of type beta transforming growth factor occurs at a level distal from receptors for growth-activating factors. J. Biol. Chem. 261:1986;13426-13429.
27. Marshall C.J. Specificity of receptor tyrosine kinase signaling transient versus sustained extracellular signal-regulated kinase activation . Cell. 80:1995;179-185.
28. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:1990;597-641.
29. Massague J., Chen Y.G. Controlling TGF-beta signaling. Genes Dev. 14:2000;627-644.
30. Mazzucchelli C., Vantaggiato C., Ciamei A., Fasano S., Pakhotin P., Krezel W., Welzl H., Wolfer D.P., Pages G., Valverde O., Marowsky A., Porrazzo A., Orban P.C., Maldonado R., Ehrengruber M.U., Cestari V., Lipp H.P., Chapman P.F., Pouyssegur J., Brambilla R. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal- mediated learning and memory. Neuron. 34:2002;807-820.
31. Miettinen P.J., Chin J.R., Shum L., Slavkin H.C., Shuler C.F., Derynck R., Werb Z. Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure. Nat. Genet. 22:1999;69-73.
32. Moghal N., Sternberg P.W. Multiple positive and negative regulators of signaling by the EGF-receptor. Curr. Opin. Cell Biol. 11:1999;190-196.
33. Pages G., Guerin S., Grall D., Bonino F., Smith A., Anjuere F., Auberger P., Pouyssegur J. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science. 286:1999;1374-1377.
34. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways regulation and physiological functions . Endocr. Rev. 22:2001;153-183.
35. Pouyssegur J., Volmat V., Lenormand P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem. Pharmacol. 64:2002;755-763.
36. Pratt R.M. Role of epidermal growth factor in embryonic development. Curr. Top. Dev. Biol. 22:1987;175-193.
37. Pratt R.M., Martin G.R. Epithelial cell death and cyclic AMP increase during palatal development. Proc. Natl. Acad. Sci. USA. 72:1975;874-877.
38. Proetzel G., Pawlowski S.A., Wiles M.V., Yin M., Boivin G.P., Howles P.N., Ding J., Ferguson M.W., Doetschman T. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11:1995;409-414.
39. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 103:2000;211-225.
40. Schutte B.C., Murray J.C. The many faces and factors of orofacial clefts. Hum. Mol. Genet. 8:1999;1853-1859.
41. Schwartz M.A., Ginsberg M.H. Networks and crosstalk integrin signalling spreads . Nat. Cell Biol. 4:2002;E65-E68.
42. Shuler C.F. Programmed cell death and cell transformation in craniofacial development. Crit. Rev. Oral Biol. Med. 6:1995;202-217.
43. Shuler C.F., Guo Y., Majumder A., Luo R.Y. Molecular and morphologic changes during the epithelial-mesenchymal transformation of palatal shelf medial edge epithelium in vitro. Int. J. Dev. Biol. 35:1991;463-472.
44. Shuler C.F., Halpern D.E., Guo Y., Sank A.C. Medial edge epithelium fate traced by cell lineage analysis during epithelial-mesenchymal transformation in vivo. Dev. Biol. 154:1992;318-330.
45. Thesleff I., Vaahtokari A., Partanen A.M. Regulation of organogenesis. Common molecular mechanisms regulating the development of teeth and other organs. Int. J. Dev. Biol. 39:1995;35-50.
46. Tohgo A., Pierce K.L., Choy E.W., Lefkowitz R.J., Luttrell L.M. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 277:2002;9429-9436.
47. Tudela C., Formoso M.A., Martinez T., Perez R., Aparicio M., Maestro C., Del Rio A., Martinez E., Ferguson M., Martinez-Alvarez C. TGF-beta3 is required for the adhesion and intercalation of medial edge epithelial cells during palate fusion. Int. J. Dev. Biol. 46:2002;333-336.
48. Tyler M.S., Pratt R.M. Effect of epidermal growth factor on secondary palatal epithelium in vitro tissue isolation and recombination studies . J. Embryol. Exp. Morphol. 58:1980;93-106.
49. Waterman H., Yarden Y. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Lett. 490:2001;142-152.
50. Young D.L., Schneider R.A., Hu D., Helms J.A. Genetic and teratogenic approaches to craniofacial development. Crit. Rev. Oral Biol. Med. 11:2000;304-317.